https://www.marketscreener.com/quote/stock/PHARNEXT-SCA-29750723/news/Pharnext-Announces-First-Patient-Enrolled-in-Open-Label-Extension-of-the-Pivotal-Phase-III-Study-of-41748728/?utm_source=telegram&utm_medium=social&utm_campaign=share